Embedding Technique Versus ILM Peeling

Embedding Technique Versus ILM Peeling

The purpose of this study was to determine the outcomes of two different surgical techniques in patients with lamellar macular holes associated with thick epiretinal membranes, termed lamellar hole-associated epiretinal proliferation (LHEP). Patients with LHEP may experience visual decline with both observation and conventional surgery, and surgery remains controversial. In this study, pars plana vitrectomy with LHEP-embedding was compared to the conventional surgical approach of internal limiting membrane (ILM) peeling. To the authors knowledge, this is the first report comparing LHEP-embedding to conventional ILM peeling.

The authors perform a retrospective observational study of 40 eyes from 39 consecutive patients with a diagnosis of LHEP treated surgically with primary pars plana vitrectomy. The study patients were seen at Osaka University Hospital between September 2010 and September 2021 and had a minimum of 3 months follow-up. Eyes with a history of myopic maculopathy, advanced glaucoma, diabetic retinopathy, age-related maculopathy, retinal vein occlusion, uveitis, and any previous intraocular surgery other than cataract surgery were excluded.

All patients were treated surgically with either 25- or 27-gauge pars plana vitrectomy that involved a core vitrectomy, intravitreal triamcinolone, induction of posterior vitreous detachment when it was absent, and peripheral shaving with scleral depression. Some cases had a fluid air exchange performed with air or 20% SF6 gas tamponade. In eyes treated with LHEP-embedding (Group E, 23 eyes), the epiretinal membrane proliferation was peeled circumferentially around the fovea and left attached at the foveal edge. The ILM was then peeled and the epiretinal proliferation was embedded into the lamellar hole and trimmed. Viscoelastic material was used to hold the epiretinal proliferation in place. In eyes treated with standard ILM peeling (Group I, 17 eyes), the epiretinal membrane proliferation and ILM were peeled off completely. For eyes in Group E, the embedded epiretinal proliferation was confirmed with optical coherence tomography (OCT) postoperatively.

The primary endpoints were postoperative best-corrected visual acuity (BCVA) and development of macular hole (MH) with an average follow-up of 23 months. Additional secondary outcomes included central retinal thickness (CRT) at the final visit and ellipsoid zone disruption at the final visit. OCT measurements were performed by a single masked observer.

Postoperative BCVA at 3 months follow-up and at the final visit was statistically significantly better in Group E. Postoperative BCVA at 3 months follow-up and at the final visit was not significantly better in Group I. Group I had lower BCVA at the final visit than preoperatively. There was no statistically significant difference in postoperative BCVA between Group E and Group I. MH did not develop postoperatively in Group E. Five eyes (29%) developed MH postoperatively in Group I. The postoperative CRT was statistically significantly different at the 3 months follow-up and the final visit follow-up between Group E and Group I, with Group E having more thickness (Group E 3 months 188mm vs Group I 3 months 109.5mm; Group E final visit 167.5mm vs Group I final visit 104.9mm). The postoperative ellipsoid zone disruption was comparable between both groups at 3 months follow-up and at the final visit. Linear regression analyses demonstrated final BCVA correlated significantly to ellipsoid zone disruption and development of MH.

While there are sample size and retrospective limitations to this study, this study demonstrates better visual and anatomic outcomes using LHEP-embedding surgical technique for LHEP as well as less postoperative complications. The study highlights additional areas that merit further research, including distinguishing between tractional epiretinal membranes versus degenerative epiretinal membranes as well as the role of LHEP-embedding in ellipsoid zone restoration, reducing MH development, and postoperative visual functioning. The authors should be commended for taking on the difficult analyses required to assess surgical technique.

Details
  • Overview

    August 2022: VBS Literature Update

    Kanai M, Sakimoto S, Takahashi S, et al. Embedding technique versus conventional internal limiting membrane peeling for lamellar macular hole with epiretinal proliferation [published online ahead of print]. Ophthalmol Retina. 2022. doi: 10.1016/j.oret.2022.07.009.

    Abstract by Nika Bagheri, MD

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Explain how lamellar hole epiretinal proliferation embedding can be achieved surgically
    • State the potential benefits of lamellar hole epiretinal proliferation embedding
    • Accreditation

       Provided by Evolve Medical Education

      Accreditation Statement
      This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education, LLC and Vit Buckle Society.  Evolve Medical Education, LLC is accredited by the ACCME to provide continuing medical education for physicians.

      Credit Designation Statement
      Evolve Medical Education LLC designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

    • Faculty and Disclosures

      Nika Bagheri, MD

      Nika Bagheri, MD

      California Retina Consultants
      Santa Barbara, CA


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

      The following faculty/staff members have the following financial relationships with ineligible companies.

      Nika Bagheri, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of ConsultantGenentech and Alcon.

      The Evolve staff and planners have no financial relationships with ineligible companies.
      Nisha Mukherjee, MD, peer reviewer, has no financial relationships with ineligible companies.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Vit Buckle Society.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Expiration Date:

    0.50 credits
    Completing the pre-test is required to access this content.
    Completing the pre-survey is required to view this content.

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    Register

    We're glad to see you're enjoying Evolve Medical Education…
    but how about a more personalized experience?

    Register for free